ABSTRACT
Hidradenitis Suppurativa (HS) is recently attracting much attention and awareness, often because it is misdiagnosed for years, restricting the therapeutic options. Moreover, this pathology arises in areas such as the inguinal region, that may cause embarrassment in young patients. Wrong diagnosis and delay in appropriate treatments lead to an exacerbation of the symptoms and a progression of the disease, which at the last stage can only be managed through extensive surgical excisions, ablation and vaporization of nodules with CO2 laser systems or aggressive chemotherapies such as anti-TNF-alpha like adalimumab (Humira®-AbbVie Inc. North Chicago, Illinois USA). In our study, we present an alternative low-invasive treatment that presents a successful outcome, supported by clinical and histological evaluation, limited however only for early stages of HS, highlighting the importance of raising awareness among physicians and patients by stressing the importance of an early diagnosis.
